StockClub

NWBO

NWBONorthwest Biotherapeutics, Inc.$ --
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

NWBO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M USD
YoY -44.0%
Operating Income
-14M USD
YoY +3.2%
Net Income
-27M USD
YoY -38.5%
EPS
-0.02$
YoY -17.4%

Revenue

$706,000
FY2023 Q4$1.9M
$1.9M
Q4
FY2024 Q1$284,000
$284,000
Q1
FY2024 Q2$794,000
$794,000
Q2
FY2024 Q3$1.2M
$1.2M
Q3
FY2024 Q4$1.4M
$1.4M
Q4
FY2025 Q1$375,000
$375,000
Q1
FY2025 Q2$506,000
$506,000
Q2
FY2025 Q3$706,000
$706,000
Q3
Actual
$-445,000 (-38.7%)

Net Income

$-61.8M
FY2023 Q4$-63.1M
$-63.1M
Q4
FY2024 Q1$-18.3M
$-18.3M
Q1
FY2024 Q2$-36.2M
$-36.2M
Q2
FY2024 Q3$-55.6M
$-55.6M
Q3
FY2024 Q4$-83.8M
$-83.8M
Q4
FY2025 Q1$-19.6M
$-19.6M
Q1
FY2025 Q2$-35M
$-35M
Q2
FY2025 Q3$-61.8M
$-61.8M
Q3
Actual
$-6.3M (-11.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$2.4M
FY2019
$2.4M
FY2020
Actual:$1.3M
FY2020
$1.3M
FY2021
Actual:$1M
FY2021
$1M
FY2022
Actual:$1.7M
FY2022
$1.7M
FY2023
Actual:$1.9M
FY2023
$1.9M
FY2024
Actual:$1.4M
FY2024
$1.4M

Analyst Estimates

No forecast data